Bristow; Cynthia L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bristow; Cynthia L..The latest application filed is for "therapeutic use of levorotatory beta-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels".

Company Profile

4.9.27

Bristow; Cynthia L. - Long Beach NY
Bristow; Cynthia L. - New York NY
Bristow; Cynthia L. - Dix Hills NY US
Bristow; Cynthia L. - Roslyn NY
Bristow; Cynthia L - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Use Of Levorotatory Beta-lactams In Hematopoiesis, Immuno-oncology Therapy, And Regulation Of Lipoprotein And Apolipoprotein Levels App 20220273626 - Bristow; Cynthia L. ; et al.	2022-09-01
Therapeutic use of levorotatory .beta.-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels Grant 11,324,730 - Bristow , et al. May 10, 2	2022-05-10
Therapeutic Use Of Tromethamine Salt Of L-ampicillin In Hematopoiesis, Immuno-oncology Therapy, And Regulation Of Lipoprotein And Apolipoprotein Levels App 20200383955 - Bristow; Cynthia L. ; et al.	2020-12-10
Therapeutic use of tromethamine salt of L-ampicilline in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels Grant 10,709,693 - Bristow , et al.	2020-07-14
Therapeutic use for .alpha..sub.1 proteinase inhibitor in hematopoiesis Grant 10,539,551 - Bristow Ja	2020-01-21
Therapeutic Use Of Levorotatory B-lactams In Hematopoiesis, Immuno-oncology Therapy, And Regulation Of Lipoprotein And Apolipopr App 20200016128 - Bristow; Cynthia L. ; et al.	2020-01-16
Pharmaceutical composition containing the tromethamine salt of L-ampicillin Grant 10,413,530 - Bristow , et al. Sept	2019-09-17
Therapeutic Use Of Levorotatory Ss-lactams In Hematopoiesis, Immuno-oncology Therapy, And Regulation Of Lipoprotein And Apolipoprotein Levels App 20180221349 - Bristow; Cynthia L. ; et al.	2018-08-09
Ldl Quantitation And Methods Of Use App 20180092964 - Bristow; Cynthia L.	2018-04-05
Therapeutic Use for Alpha1 Proteinase Inhibitor in Hematopoiesis App 20180003699 - Bristow; Cynthia L.	2018-01-04
Therapeutic use for ALPHA1 proteinase inhibitor in hematopoiesis Grant 9,612,233 - Bristow April 4, 2	2017-04-04
Alpha1 proteinase inhibitor peptides methods and use App 20150011479 - Bristow; Cynthia L.	2015-01-08
Cell Free CD4 Quantitation and Methods of Use App 20140322741 - Bristow; Cynthia L.	2014-10-30
Method For Decreasing Low Density Lipoprotein Levels App 20140005108 - Bristow; Cynthia L.	2014-01-02
Ldl Quantitation And Method Of Use App 20130023472 - Bristow; Cynthia L.	2013-01-24
Cell Free Cd4 Quantitation And Methods Of Use App 20130022991 - Bristow; Cynthia L.	2013-01-24
Modulation Of Plasma Membrane Human Leukocyte Elastase App 20130017601 - Bristow; Cynthia L.	2013-01-17
Therapeutic Use For Alpha1 Proteinase Inhibitor In Hematopoiesis App 20120172286 - Bristow; Cynthia L.	2012-07-05
Detection of surface-associated human leukocyte elastase Grant 7,833,735 - Bristow November 16, 2	2010-11-16
Alpha1 proteinase inhibitor peptides methods and use App 20100029558 - Bristow; Cynthia L.	2010-02-04
Detection of surface-associated human leukocyte elastase App 20060234312 - Bristow; Cynthia L.	2006-10-19
Modulation of plasma membrane Human Leukocyte Elastase App 20060183214 - Bristow; Cynthia L.	2006-08-17
Detection of surface-associated human Leukocyte Elastase App 20050164315 - Bristow, Cynthia L.	2005-07-28
Detection of surface-associated human leukocyte elastase Grant 6,858,400 - Bristow February 22, 2	2005-02-22
Modulation of plasma membrane human leukocyte elastase App 20030138427 - Bristow, Cynthia L.	2003-07-24
Modulation of plasma membrane human leukocyte elastase App 20020009788 - Bristow, Cynthia L.	2002-01-24
Detection of surface-associated human leukocyte elastase App 20020004212 - Bristow, Cynthia L.	2002-01-10
Therapeutic administration of a modified alpha1 proteinase inhibitor App 20020004477 - Bristow, Cynthia L.	2002-01-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.